McKesson had its Relative Strength (RS) Rating upgraded from 73 to 81 Wednesday.
IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matches up against that of all other stocks.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating as they launch their biggest price moves.
Risk Management In The Stock Market: How Much Money To Invest Now
McKesson is building a cup with handle with a 632.59 entry. See if the stock can break out in volume at least 40% higher than normal.
The company posted 4% EPS growth last quarter, while sales growth came in at 18%.
McKesson earns the No. 2 rank among its peers in the Medical-Wholesale Drugs industry group. is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
